Drug Pricing Issues to Watch in 2022

Federal Lawmakers Turn Their Sights to Drug Pricing, Introducing a Package of Bills Seeking Changes to Antitrust and Patent Law

President Biden Signs Legislation Boosting Generic and Biosimilar Drugs

Elimination of Medicaid Rebate Cap in the Latest COVID-19 Relief Package—The First Legislative Action on Drug Pricing Under the Biden Administration